Medicofarma Biotech (WAR:MDB) Buyback Yield %: 0.00 (As of Jul. 07, 2026)

What is Medicofarma Biotech Buyback Yield %?

Medicofarma Biotech WAR:MDB +4.41% 33 Buyback Yield % is 0.00 as of Jul. 07, 2026. GuruFocus rates WAR:MDB with a GF Score™ of 33/100 and a GF Value™ of zł0.05 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 291 Drug Manufacturers companies, Medicofarma Biotech ranks worse than 343642.27% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Medicofarma Biotech's current buyback yield was 0.00%.

Medicofarma Biotech Buyback Yield % Related Terms

Medicofarma Biotech Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Medicofarma Biotech's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicofarma Biotech Buyback Yield % Chart

Medicofarma Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Buyback Yield %

Get a 7-Day Free Trial

-12.68

0.00

Medicofarma Biotech Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Buyback Yield %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

WAR:MDB vs ZTS, UTHR, VTRS: Buyback Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medicofarma Biotech's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicofarma Biotech Buyback Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicofarma Biotech's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Medicofarma Biotech's Buyback Yield % falls into.

Save Embed

33GF Score

Medicofarma Biotech SA WAR:MDB

Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Medicofarma Biotech Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Medicofarma Biotech's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	0)	/	27.123222
	=	0.00%

Medicofarma Biotech's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	0)		/	34.66878
	=	0.00%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →

What does a Buyback Yield % of 0.00 mean?

Medicofarma Biotech (WAR:MDB) has a Buyback Yield % of 0.00 as of Jul. 07, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Medicofarma Biotech and its competitors. According to the industry distribution chart, Medicofarma Biotech ranks #999999 out of 291 companies in the Drug Manufacturers industry.

Is Medicofarma Biotech's Buyback Yield % too high?

Medicofarma Biotech's current Buyback Yield % is 0.00. Based on the distribution chart, Medicofarma Biotech ranks #999999 out of 291 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Medicofarma Biotech has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Medicofarma Biotech's Buyback Yield % compare to ZTS and UTHR?

According to the Drug Manufacturers industry distribution chart, Medicofarma Biotech ranks #999999 out of 291 companies for Buyback Yield %. This places Medicofarma Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Buyback Yield % for a Drug Manufacturers company?

A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Buyback Yield % mean?

A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Medicofarma Biotech and its competitors. Medicofarma Biotech's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Medicofarma Biotech stock overvalued right now?

Based on GuruFocus' analysis, Medicofarma Biotech (WAR:MDB) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.05, compared to a current price of zł0.43 — trading 752% above its estimated fair value. The current Buyback Yield % is 0.00. Medicofarma Biotech's overall GF Score™ is 33/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Buyback Yield % calculated?

Buyback Yield % is calculated from a company's financial statements. For Medicofarma Biotech (WAR:MDB), the current Buyback Yield % is 0.00 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicofarma Biotech (WAR:MDB) Overvalued in 2026?

Based on GuruFocus' analysis, Medicofarma Biotech stock appears to be overvalued. The current stock price of zł0.43 is trading 752% above its estimated GF Value™ of zł0.05. GuruFocus considers Medicofarma Biotech to be Significantly Overvalued.

Key valuation signals for WAR:MDB:

Buyback Yield %: 0.00
GF Value™: zł0.05 vs. price of zł0.43 (752% above fair value)
GF Score™: 33/100 with 6 warning signs

No single metric tells the full story. See the WAR:MDB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medicofarma Biotech Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies WAR:HMP WAR:CBD WAR:BGD XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR HKSE:03692 VTRS NSE:DIVISLAB OSTO:SOBI NBIX NSE:TORNTPHARM SHSE:688506

Address ul. Sokołowska 9 lok. U19, Warsaw, POL, 01-142

Website https://www.medicofarma.pl

Medicofarma Biotech SA operates in the pharmaceutical industry. The company specializes in contract manufacturing of medical devices, medicinal products and dietary supplements. The business is spread across Austria, Czech Republic, Spain, Ireland, Canada, Germany, Norway, Sweden, Great Britain, and Italy.

33GF Score

Get the complete analysis for WAR:MDB

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.43

Price

zł0.05

GF Value

View WAR:MDB Analysis

See Buyback Yield % data for all stocks →